Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · IEX Real-Time Price · USD
2.490
+0.120 (5.06%)
Jul 22, 2024, 10:26 AM EDT - Market open
Turnstone Biologics Employees
Turnstone Biologics had 80 employees as of December 31, 2023. The number of employees decreased by 28 or -25.93% compared to the previous year.
Employees
80
Change (1Y)
-28
Growth (1Y)
-25.93%
Revenue / Employee
n/a
Profits / Employee
-$936,450
Market Cap
56.32M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 80 | -28 | -25.93% |
| Dec 31, 2022 | 108 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Allurion Technologies | 504 |
| Atara Biotherapeutics | 225 |
| Barinthus Biotherapeutics | 130 |
| Passage Bio | 58 |
| Rallybio | 43 |
| LAVA Therapeutics | 37 |
| Immix Biopharma | 17 |
| Ocuphire Pharma | 14 |
TSBX News
- 2 months ago - Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 2 months ago - Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference - GlobeNewsWire
- 3 months ago - Turnstone Biologics Appoints William Waddill to its Board of Directors - GlobeNewsWire
- 4 months ago - Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 5 months ago - Turnstone Biologics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq. - GlobeNewsWire
- 8 months ago - Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference - GlobeNewsWire
- 9 months ago - Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights - GlobeNewsWire